{"result": "(\"entity\"<|>ACIDOS GRASOS W6<|>EVENT<|>Omega-6 fatty acids (AGW6) are essential fatty acids that play a role in inflammatory responses and are a focus in lipid emulsions.)\n##\n(\"entity\"<|>ACIDOS GRASOS W3<|>EVENT<|>Omega-3 fatty acids (AGW3) are incorporated into lipid emulsions for their potential anti-inflammatory and hepatoprotective effects.)\n##\n(\"entity\"<|>VITAMINA E<|>EVENT<|>Vitamin E (alfa-tocoferol) is an antioxidant that is enriched in certain lipid emulsions, contributing to their health benefits.)\n##\n(\"entity\"<|>HIDRATACION<|>EVENT<|>Hydration is a critical aspect of patient care, influencing the management of fluid intake and losses in nutritional support.)\n##\n(\"entity\"<|>ACIDOS GRASOS OLEICOS<|>EVENT<|>Oleic acid (AGW9) is a monounsaturated fatty acid that is enriched in certain emulsions to enhance their stability and health benefits.)\n##\n(\"relationship\"<|>TCL INTRALIPID<|>ACIDOS GRASOS W6<|>TCL Intralipid is designed to provide omega-6 fatty acids, which are essential for various bodily functions and inflammatory responses.<|>7)\n##\n(\"relationship\"<|>CLINOLEIC<|>ACIDOS GRASOS OLEICOS<|>Clinoleic is enriched with oleic acid, enhancing its stability and health benefits, indicating a relationship in their formulation.<|>6)\n##\n(\"relationship\"<|>LIPOPLUS<|>ACIDOS GRASOS W3<|>Lipoplus incorporates omega-3 fatty acids, which are known for their anti-inflammatory properties, indicating a relationship in their health benefits.<|>5)\n##\n(\"relationship\"<|>ELECTROLYTES<|>HIDRATACION<|>Electrolytes are crucial for maintaining hydration and fluid balance in patients, indicating a direct relationship in clinical management.<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: éridos de cadena larga (TCL) Intralipid®. Derivadas del aceite de soja. Inicialmente el objetivo de las emulsiones lipídicas era proporcionar AGE, fundamentalmente ácido linoleico (ácidos grasos W6, AGW6). La alta proporción de AGW6 de estas emulsiones incrementa la síntesis de prostaglandinas de la serie 2 y, por lo tanto, la respuesta inflamatoria. Además, son más inestables y se peroxidan con mayor facilidad, por tanto tienen un efecto proinflamatorio.\n\n* Segunda generación: En los años 80, se introdujeron los triglicéridos de cadena media (TCM), procedentes del aceite de coco, para disminuir el aporte de AGW6.\n\nLos TCM se caracterizan por41:\n\n- Rapidez de oxidación. No necesitan carnitina.\n- Resistentes a la peroxidación lipídica con menor producción de radicales libres.\n- No son almacenados como triglicéridos, menor esteatosis hepática.\n- No participan en la síntesis de eicosanoides, por tanto son inmunológicamente e inflamatoriamente neutros.\n- Sin embargo, son más cetogénicos (por su rápida oxidación) y no aportan AGE.\n\nExisten dos tipos de EL de segunda generación:\n\n- Mezcla física de TCL con TCM al 50%, lipofundina® (50% aceite de soja/50% aceite de palma).\n- Emulsiones de lípidos estructurados, Structolipid® (64% aceite de soja/37% aceite de palma): Lípidos sintéticos a través de la hidrólisis de aceite de coco y de soja. Menores alteraciones hepáticas que las emulsiones de mezcla física.\n\n* Tercera generación: Se introdujeron en los años 90.\n\n- Emulsiones enriquecidas en aceite de oliva, Clinoleic® (80% aceite de oliva/20% aceite de soja). Enriquecidos en ácido oleico\n\n(AGW9) presentan una mayor resistencia a la peroxidación lipídica, menor generación de mediadores proinflamatorios e inmunitariamente son neutras. Tienen un alto efecto antioxidante por un alto contendido en vitamina E (alfa-tocoferol)42.\n\n* Cuarta generación: Incorporación de ácidos grasos W3 (AGW3) y disminución del aporte AGW6. Estudios recientes han asociado el uso de estas EL a un efecto antiinflamatorio e inmunomodulador y a un probable efecto protector hepático39, 43, 44.\n\nLas EL de cuarta generación disponibles son:\n\n- Emulsiones con 10% de aceite de pescado, 40% de aceite de soja y 50% de aceite de palma, Lipoplus®. Incorporación de AGW3 a las EM de segunda generación.\n- Emulsiones con 30% de aceite de soja, 30% de aceite de coco, 25% de aceite de oliva, 15% de aceite de pescado. SMOFlipid®. Se considera una EL con una composición balanceada y más fisiológica que el resto39.\n\n5.2. Volumen\n\nLos requerimientos hídricos variarán en función de la situación clínica del paciente durante su evolución. Es fundamental realizar un correcto balance hídrico teniendo en cuenta todos los aportes y pérdidas de fluidos. Debemos añadir, a las pérdidas hídricas, 500-800 ml al día de pérdidas insensibles en sujetos euvolémicos y sin alteración de la función renal. Habitualmente, se recomienda un aporte total de fluidos de 30-35 ml/kg/día.\n\nEl cálculo del aporte de volumen de la NP se realiza usando soluciones de macronutrientes en mayor o menor concentración. Existen soluciones con concentraciones de glucosa del 5-70%, de lípidos 10-30% y de AA del 10-15%. Las vitaminas, electrolitos y oligoelementos aportarán únicamente 25-80 ml del volumen total de la bolsa de NP25.\n\n5.3. Electrolitos y minerales\n\nEl aporte de los electrolitos y minerales, vendrá determinado por los requerimientos del paciente (tabla 1)19, y de su situación clínica. Es fundamental valorar el incremento de necesidades, como ocurre en los pacientes con pérdidas digestivas de electrolitos (tabla 2).\n\nEl sodio y potasio se añaden a la NP como sales de acetato, fosfato o cloro.\nEl uso de acetato o cloro se adaptará a la situación de los pacientes25:\n\n* En acidosis metabólica: se usarán sales de acetato (como precursor de bicarbonato).\n* En alcalosis metabólica, sales de cloro.\n---\n768      BLOQUE: SOPORTE NUTRICIONAL AVANZADO\n\nTabla 1. Requerimientos diarios de elect\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>TCL INTRALIPID<|>ORGANIZATION<|>TCL Intralipid is a product derived from soybean oil, used for providing essential fatty acids and influencing inflammatory responses through lipid emulsions.)\n##\n(\"entity\"<|>AGE<|>EVENT<|>AGE refers to essential fatty acids, particularly linoleic acid, which are crucial for various bodily functions and are provided by lipid emulsions.)\n##\n(\"entity\"<|>TCM<|>ORGANIZATION<|>Triglycerides of medium chain (TCM) are derived from coconut oil and are used to reduce the intake of omega-6 fatty acids in nutritional support.)\n##\n(\"entity\"<|>LIPOFUNDINA<|>ORGANIZATION<|>Lipofundina is a mixture of triglycerides of long chain and medium chain fatty acids, specifically 50% soybean oil and 50% palm oil.)\n##\n(\"entity\"<|>STRUCTOLIPID<|>ORGANIZATION<|>Structolipid is a synthetic lipid emulsion made from the hydrolysis of coconut and soybean oil, designed to minimize hepatic alterations.)\n##\n(\"entity\"<|>CLINOLEIC<|>ORGANIZATION<|>Clinoleic is an enriched emulsion containing 80% olive oil and 20% soybean oil, known for its high antioxidant effect due to vitamin E content.)\n##\n(\"entity\"<|>LIPOPLUS<|>ORGANIZATION<|>Lipoplus is a fourth-generation emulsion containing 10% fish oil, 40% soybean oil, and 50% palm oil, incorporating omega-3 fatty acids.)\n##\n(\"entity\"<|>SMOFLIPID<|>ORGANIZATION<|>SMOFlipid is a balanced lipid emulsion containing 30% soybean oil, 30% coconut oil, 25% olive oil, and 15% fish oil, considered more physiological.)\n##\n(\"entity\"<|>ELECTROLYTES<|>EVENT<|>Electrolytes are minerals that are essential for various bodily functions and are added to nutritional support based on patient needs.)\n##\n(\"entity\"<|>FLUID BALANCE<|>EVENT<|>Fluid balance refers to the management of fluid intake and losses in patients, crucial for their clinical situation and hydration needs.)\n##\n(\"relationship\"<|>TCL INTRALIPID<|>AGE<|>TCL Intralipid provides essential fatty acids, which are crucial for the body's functions, including the synthesis of AGE.<|>7)\n##\n(\"relationship\"<|>TCM<|>TCL INTRALIPID<|>TCM is introduced to reduce the intake of omega-6 fatty acids in nutritional support, which is a key aspect of TCL Intralipid's formulation.<|>6)\n##\n(\"relationship\"<|>LIPOFUNDINA<|>TCM<|>Lipofundina is a physical mixture of TCL and TCM, indicating a direct relationship in their composition.<|>8)\n##\n(\"relationship\"<|>STRUCTOLIPID<|>TCL INTRALIPID<|>Structolipid is a synthetic alternative to traditional lipid emulsions like TCL Intralipid, showing a relationship in their purpose.<|>5)\n##\n(\"relationship\"<|>CLINOLEIC<|>TCL INTRALIPID<|>Clinoleic is a third-generation emulsion that builds on the principles of TCL Intralipid, indicating a relationship in their development.<|>6)\n##\n(\"relationship\"<|>LIPOPLUS<|>TCL INTRALIPID<|>Lipoplus incorporates omega-3 fatty acids into the formulation of lipid emulsions, showing a relationship in their evolution.<|>5)\n##\n(\"relationship\"<|>SMOFLIPID<|>LIPOPLUS<|>SMOFlipid is considered a more physiological lipid emulsion compared to Lipoplus, indicating a relationship in their formulation approaches.<|>4)\n##\n(\"relationship\"<|>ELECTROLYTES<|>FLUID BALANCE<|>Electrolytes are added to nutritional support to maintain fluid balance in patients, indicating a direct relationship in clinical management.<|>8)\n<|COMPLETE|>"}]}